Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)

The NIH’s funding opportunity (PA-25-121) supports R01 grant applications for epidemiologic research on emerging and established risk factors contributing to liver cancer susceptibility in the United States. This initiative focuses on investigating new hypotheses about biological, environmental, and social factors that may influence liver cancer risk, alongside traditional risk factors such as viral hepatitis. This grant does not permit clinical trials. Eligible applicants include higher education institutions, local and state governments, tribal governments, nonprofits, for-profit organizations, and minority-serving institutions such as HBCUs and Hispanic-serving Institutions. While foreign institutions may not apply directly, they can participate as components of U.S.-based projects. Applications are due by May 7, 2025, with an archive date of June 12, 2025. No cost-sharing is required, and funding specifics are not disclosed. Applicants are encouraged to develop comprehensive epidemiologic research strategies to advance understanding of liver cancer risk, with full guidance available in the NIH announcement. For more details, interested applicants should contact NIH Grants Information.